FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt

BSE1496.7537.1 (+2.54 %)

PREV CLOSE (Rs.) 1459.65

OPEN PRICE (Rs.) 1462.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 31015

TODAY'S LOW / HIGH (Rs.)1462.00 1536.35

52 WK LOW / HIGH (Rs.)918.85 1870

NSE1493.7033.1 (+2.27 %)

PREV CLOSE( Rs. ) 1460.60

OPEN PRICE (Rs.) 1460.60

BID PRICE (QTY) 1493.70 (10289)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 521730

TODAY'S LOW / HIGH(Rs.) 1460.60 1535.40

52 WK LOW / HIGH (Rs.)915 1868.8

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

467.01

Dividend Yield(%)

0.00

TTM EPS (Rs.)

3.14

P/E Ratio

476.88

Book Value (Rs.)

173.62

Face Value (Rs.)

MCap (Rs. in Mn)

243210.15

Price/Earning (TTM)

109.55

Price/Sales (TTM)

16.62

Price/Book (MRQ)

8.62

PAT Margin (%)

-0.85

ROCE (%)

4.75

Incorporation Year : 08-07 1999

Management Info :

Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone : 0240-6632222 / 6694444

Email : investorrelations@wockhardt.com

Website : www.wockhardt.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

28Jul Wockhardt informs about press release
Pursuant to Regulation 30 of Listing Regulations, Wockhardt has informed..

11Jul Wockhardt initiates strategic realignm
Wockhardt is undertaking significant strategic realignment of its US bus..

11Jul Wockhardt informs about press release
Wockhardt has informed that it enclosed Press Release ‘Wockhardt Initiat..

Financials

	QTR Jun 25	ANNUAL 25
Net Profit	690	-120
Gross Profit	690	-120
Operating Profit	1560	3550
Net Sales	4130	14020

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)

9105.75 (0.80%)

M.Cap (Rs. in Cr)22764.38

Glenmark Pharma (BSE)

2116.25 (3.10%)

M.Cap (Rs. in Cr)59720.75

Gland Pharma (BSE)

1919.35 (2.72%)

M.Cap (Rs. in Cr)31622.52

Dr. Reddy's Lab (BSE)

1293.45 (3.45%)

M.Cap (Rs. in Cr)107952.28

Shareholding Pattern

	PROMOTERS	49.09%
	NON-INSTITUTION	32.6%
	MUTUAL FUNDS/UTI	8.02%
	FI/BANKS/INSURANCE	0.46%
	GOVERNMENT	0.02%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Samco Active Moment...

6.08

ITI Focused Fund-Reg(G)

4.86

Tata India Pharma &...

3.67

HDFC Pharma and Hea...

2.98

Tata Small Cap Fund...

2.96

ITI Pharma & Health...

2.91

Union Active Moment...

2.63

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

WOCKHARDT LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives